References
- Wu JT, Leung K, Leung GM. Nowcasting and forecasting the potential domestic and international spread of the 2019-nCoV outbreak originating in wuhan, China: a modelling study. Lancet. 2020;395(10225):689–697.
- Docherty AB, Harrison EM, Green CA, et al. Features of 20 133 UK patients in hospital with covid-19 using the ISARIC WHO clinical characterisation protocol: prospective observational cohort study. BMJ. 2020;369(March):1–12.
- Cummings MJ, Baldwin MR, Abrams D, et al. Epidemiology, clinical course, and outcomes of critically ill adults with COVID-19 in New York city: a prospective cohort study. Lancet. 2020;395(10239):1763–1770.
- Lewnard JA, Liu VX, Jackson ML, et al. Incidence, clinical outcomes, and transmission dynamics of severe coronavirus disease 2019 in California and Washington: prospective cohort study. BMJ. 2020;369(9):m1923
- Cao J, Tu W-J, Cheng W, et al. Clinical features and short-term outcomes of 102 patients with coronavirus disease 2019 in wuhan, China. Clin Infect Dis. 2020;71(15):748–755.
- Beigel JH, Tomashek KM, Dodd LE, ACTT-1 Study Group Members, et al. Remdesivir for the treatment of covid-19 — final report. N Engl J Med. 2020;383(19):1813–1826.
- National Institutes of Health. COVID-19 Treatment Guidelines. 2021. https://www.covid19treatmentguidelines.nih.gov/
- Group RC. Dexamethasone in hospitalized patients with covid-19. N Engl J Med. 2021;384(8):693–704.
- Lu Y, Jiao Y, Graham DJ, et al. Risk factors for COVID-19 deaths among elderly nursing home medicare beneficiaries in the prevaccine period. J Infect Dis. 2022;225(4):567–577.
- Bar-On YM, Goldberg Y, Mandel M, et al. Protection of BNT162b2 vaccine booster against covid-19 in Israel. N Engl J Med. 2021;385(15):1393–1400.
- Somani SS, Richter F, Fuster V, Mount Sinai COVID Informatics Center, et al. Characterization of patients who return to hospital following discharge from hospitalization for COVID-19. J Gen Intern Med. 2020;35(10):2838–2844.
- Ramos-Martínez A, Parra-Ramírez LM, Morrás I, et al. Frequency, risk factors, and outcomes of hospital readmissions of COVID-19 patients. Sci Rep. 2021;11(1):1–10.
- Donnelly JP, Wang XQ, Iwashyna TJ, et al. Readmission and death after initial hospital discharge among patients with COVID-19 in a large multihospital system. JAMA - J Am Med Assoc. 2021;325(3):304–306.
- Dinh A, Mercier J-C, Jaulmes L, AP-HP/Universities/INSERM COVID-19 Research Collaboration, et al. Safe discharge home with telemedicine of patients requiring nasal oxygen therapy after COVID-19. Front Med (Lausanne). 2021;8:703017.
- Banerjee J, Canamar CP, Voyageur C, et al. Mortality and readmission rates among patients with COVID-19 after discharge from acute care setting with supplemental oxygen. JAMA Netw Open. 2021;4(4):e213990–6.
- Richardson S, Hirsch JS, Narasimhan M, the Northwell COVID-19 Research Consortium, et al. Presenting characteristics, comorbidities, and outcomes among 5700 patients hospitalized with COVID-19 in the New York city area. JAMA - J Am Med Assoc. 2020;323(20):2052–2059.
- Bouzid D, Visseaux B, Kassasseya C, IMProving Emergency Care (IMPEC) FHU Collaborators Group, et al. Comparison of patients infected with Delta versus omicron COVID-19 variants presenting to paris emergency departments : a retrospective cohort study. Ann Intern Med. 2022;175(6):831–837.
- Rzymski P, Pazgan-Simon M, Kamerys J, et al. Severe breakthrough COVID-19 cases during six months of Delta variant (B.1.617.2) Domination in Poland. Vaccines. 2022;10(4):557.
- Jassat W, Abdool Karim SS, Mudara C, et al. Clinical severity of COVID-19 in patients admitted to hospital during the omicron wave in South Africa: a retrospective observational study. Lancet Glob Heal. 2022;10(7):e961–e969.